Bulfinch Signs Lease with Infinity Pharmaceuticals at Iconic 784 Memorial Drive in Cambridge
NEEDHAM, MA.- November 11, 2014 - The Bulfinch Companies, Inc., a private commercial real estate investment firm, is pleased to announce that Infinity Pharmaceuticals, Inc. signed a lease to expand its headquarters to include 784 Memorial Drive in Cambridge, MA. The iconic building was once home to the world-headquarters of Polaroid Corp. for some 70 years. The Building, located directly along the Charles River, will provide Infinity with additional space and the opportunity to expand its operations in one of the country’s top life sciences markets.
“We are pleased to welcome Infinity to our roster of tenants and to offer them the ideal expansion space to further support and advance their research and development efforts,” said Michael Wilcox, Director of Leasing for Bulfinch. “784 Memorial Drive is at the epicenter of innovation in Cambridge and is an ideal location for Infinity to grow and expand their presence in Cambridge and one that offers a tremendous degree of visibility.”
“The expansion to 784 Memorial Drive provides us with additional space without needing to move our campus and is critical as we continue to build Infinity, advance our late-stage clinical studies, and prepare for potential commercialization,” stated Adelene Perkins, chair, president and chief executive officer at Infinity. “The former Polaroid site represents science and innovation, both of which are central to our values and mission at Infinity. We look forward to moving into this space.”
About The Bulfinch Companies, Inc.
Bulfinch is an entrepreneurial, value-added real estate investment firm specializing in the development, acquisition, management, and repositioning of commercial properties in Greater Boston. Since its inception in 1936, Bulfinch has developed, acquired and repositioned more than $1 billion in commercial real estate. www.bulfinch.com